Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Self-Efficacy01:29

Self-Efficacy

234
Self-efficacy is the belief in one's capacity to organize and execute actions necessary to manage prospective situations. This belief significantly influences how individuals approach goals, tasks, and challenges across different domains of life.Psychological and Educational ImpactsIndividuals with strong self-efficacy are more resilient in the face of difficulties. They are more likely to adopt effective problem-solving strategies, persist through obstacles, and regulate emotions such as...
234
Proteomics01:33

Proteomics

9.8K
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
9.8K
Factors Affecting Drug Distribution: Organ Perfusion Rate01:15

Factors Affecting Drug Distribution: Organ Perfusion Rate

619
Drug distribution within the body is a complex process influenced by several factors, including perfusion rate, the rate at which the bloodstream transports drugs to tissue. This limitation becomes particularly significant when dealing with highly lipophilic drugs. In such cases, the rate at which the drug can move across membranes is crucial, and if the membrane is highly permeable to the drug, distribution becomes rate-limited by perfusion.
Perfusion rate-limited distribution relies on the...
619
Therapeutic Drug Monitoring: Drug Analysis Methods01:26

Therapeutic Drug Monitoring: Drug Analysis Methods

213
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
213
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

2.1K
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
2.1K
Levels of Organization01:09

Levels of Organization

141.6K
Biological organization is the classification of biological structures, ranging from atoms at the bottom of the hierarchy to the Earth's biosphere. Each level of the hierarchy represents an increase in complexity that builds upon the previous level.
Molecules Are Composed of Atoms, and Biomolecules Are Assembled from Molecules:
The most basic levels include atoms, molecules, and biomolecules. Atoms, the smallest unit of ordinary matter, are composed of a nucleus and electrons. Molecules...
141.6K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Targeting mitochondrial protease in diffuse gliomas.

Molecular cancer therapeutics·2026
Same author

Divergent roles of SPOP and CHD1 in ACSL4 regulation reveal context-dependent vulnerabilities for targeting ferroptosis.

Nature communications·2026
Same author

Personalized targeting of BCL2 family proteins overcomes acquired resistance to BRAF-MEK inhibitors in preclinical melanoma.

Nature communications·2026
Same author

CHD1L maintains genome integrity by facilitating okazaki fragment maturation.

Nucleic acids research·2026
Same author

Aerobic Exercise Activates S1PR1 Signaling in Tumor Endothelial Cells to Promote Vascular Function in Pancreatic Cancer.

Cancer research·2026
Same author

LATS1/2-CD38 Metabolic Rewiring Links Senescence to Intraplaque Thrombosis.

Circulation research·2026

関連する実験動画

Updated: Feb 11, 2026

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
12:03

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Published on: September 5, 2016

8.3K

薬剤有効性および毒性分析のためのハイスループットマルチオルガンプロテオミクスワークフロー

Yun Xiong1,2,3, Lin Tan1,2,3, Wai-Kin Chan1,3

  • 1Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, TX, USA.

Nature communications
|February 9, 2026
PubMed
まとめ

新しいハイスループット質量分析法により、1日あたり240を超えるサンプルのプロテオーム分析が迅速に行えます。この技術は、薬剤効果に関する深い生物学的洞察を提供し、システムズバイオロジーの研究を加速します。

キーワード:
ハイスループットプロテオミクス質量分析システムズバイオロジー薬剤効果毒性分析nDIAマイクロフローLCプロテオーム前臨床モデル代謝経路

さらに関連する動画

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments
07:50

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments

Published on: October 25, 2024

2.4K
JUMPn: A Streamlined Application for Protein Co-Expression Clustering and Network Analysis in Proteomics
07:28

JUMPn: A Streamlined Application for Protein Co-Expression Clustering and Network Analysis in Proteomics

Published on: October 19, 2021

3.7K

関連する実験動画

Last Updated: Feb 11, 2026

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
12:03

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Published on: September 5, 2016

8.3K
Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments
07:50

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments

Published on: October 25, 2024

2.4K
JUMPn: A Streamlined Application for Protein Co-Expression Clustering and Network Analysis in Proteomics
07:28

JUMPn: A Streamlined Application for Protein Co-Expression Clustering and Network Analysis in Proteomics

Published on: October 19, 2021

3.7K

科学分野:

  • プロテオミクス
  • システムズバイオロジー
  • 質量分析

背景:

  • 複雑なプロテオームのハイスループット分析は、システムズバイオロジーにとって重要です。
  • 既存の方法では、多数のサンプルセットに対して時間がかかる場合があります。

研究 の 目的:

  • ハイスループット質量分析（MS）プロテオミクス法を開発および検証すること。
  • この方法を前臨床モデルにおける薬剤効果の分析に適用すること。

主な方法:

  • ナローウィンドウデータ非依存型取得（nDIA）とショートグラジエントマイクロフロークロマトグラフィーの統合。
  • 1日あたり240サンプル以上のプロファイリングを実現しました。
  • L-アスパラギナーゼ（ASNase）またはその変異体で処理した507のマウス組織サンプルの分析。

主要な成果:

  • 1分および2分勾配でそれぞれ6,201および7,466のヒトタンパク質を同定しました。
  • 薬剤処理後の11,472タンパク質の定量的プロファイルを生成しました。
  • ASNaseのアミノ酸代謝への影響、抗凝固薬およびコレステロール代謝の抑制を確認し、組織特異的な調節不全経路を明らかにしました。

結論:

  • 最適化されたハイスループットプロテオミクス法は、システムレベルの分析を大幅に加速します。
  • 前臨床モデルから生物学的洞察と臨床的に実行可能な仮説を生成できます。